# OncoFusion Therapeutics, Inc. — Form D

OncoFusion Therapeutics, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-01. The offering totals $750K, of which $525K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2013-03-01
- Form: D
- Accession: 0001570291-13-000002
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $750K
- Amount sold: $525K
- Remaining: $225K
- Investors: 9
- Date of first sale: 2013-02-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-192602

## Issuer

- Name: OncoFusion Therapeutics, Inc.
- CIK: 0001570291
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1600 HURON PARKWAY, ANN ARBOR, MI, 48109
- Phone: 734-615-0362

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Mel Sorensen, M.D. | Director | Ann Arbor, MI |
| Shaomeng Wang | Director | Malvern, PA |
| Peter Sugar | Executive Officer | Southfield, MI |
| Shaomeng Wang | Executive Officer | Malvern, PA |

## More

- [CIK 1570291 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1570291&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001570291-13-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.